DANAHER CORP /DE/ (DHR)
About DANAHER CORP /DE/
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $24.6B
- Net income
- $3.6B
- Total assets
- $83.5B
- Market cap
- $130.4B
- Gross margin
- 59.1%
- Operating margin
- 19.1%
- Net margin
- 14.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $24.6B
- Cost of revenue
- $10.0B
- Gross profit
- $14.5B
- Operating expenses
- $9.8B
- Operating income
- $4.7B
- Income tax
- $633.0M
- Net income
- $3.6B
- EPS (basic)
- $5.07
- EPS (diluted)
- $5.05
Balance sheet
- Total assets
- $83.5B
- Current assets
- $12.8B
- Total liabilities
- $30.9B
- Current liabilities
- $6.8B
- Shareholders’ equity
- $52.5B
Cash flow
- Operating cash flow
- $6.4B
- Investing cash flow
- -$1.2B
- Financing cash flow
- -$3.0B
- Net cash flow
- $2.5B
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $130.4B
- P/E ratio
- 37.9
- EPS (diluted)
- $5.05
- Dividend yield
- 0.84%
- Shares outstanding
- 681.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 29, 1978
Danaher Corp /DE/ (DHR) Stock Price
- Profitable — net income of $3.6B in FY2025.
- Revenue declined 17% from FY2021 to FY2025.
- Gross margin of 59.1%, net margin 14.7%.
- Trading 21% below its 52-week high.
- Pays a dividend yielding about 0.84% annually.
- Valued at a price-to-earnings (P/E) ratio of 37.9.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review DANAHER CORP /DE/.
Write a review
News about DANAHER CORP /DE/
News & sentiment via Polygon.io
Danaher Corp /DE/: frequently asked questions
Is Danaher Corp /DE/ an American company?
Yes — Danaher Corp /DE/ is an American company headquartered in Washington, District of Columbia. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Danaher Corp /DE/ headquartered?
Danaher Corp /DE/ is headquartered in Washington, District of Columbia, United States.
Is Danaher Corp /DE/ publicly traded?
Yes — Danaher Corp /DE/ is a publicly traded company. Its stock trades under the ticker symbol DHR on the NYSE.
What does Danaher Corp /DE/ do?
Danaher Corp /DE/ is an American Medical Devices company in the Health & Beauty sector.
